You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Details for New Drug Application (NDA): 076204

✉ Email this page to a colleague

« Back to Dashboard

NDA 076204 describes MOEXIPRIL HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Pharms Ltd, Teva, Glenmark Pharms, and Heritage, and is included in eight NDAs. It is available from three suppliers. Additional details are available on the MOEXIPRIL HYDROCHLORIDE profile page.

The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.

Summary for 076204

Tradename:	MOEXIPRIL HYDROCHLORIDE
Applicant:	Teva
Ingredient:	moexipril hydrochloride
Patents:	0

Pharmacology for NDA: 076204

Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Suppliers and Packaging for NDA: 076204

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	076204	ANDA	Teva Pharmaceuticals USA, Inc.	0093-0017	0093-0017-01	100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01)
MOEXIPRIL HYDROCHLORIDE	moexipril hydrochloride	TABLET;ORAL	076204	ANDA	Teva Pharmaceuticals USA, Inc.	0093-5150	0093-5150-01	100 TABLET, FILM COATED in 1 BOTTLE (0093-5150-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	7.5MG
Approval Date:	May 8, 2003	TE:	AB	RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	15MG
Approval Date:	May 8, 2003	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.